Question 1

How many shares of SGMO does WELLS FARGO & COMPANY/MN own?

Accepted Answer

WELLS FARGO & COMPANY/MN previously held 0 shares of SGMO (SANGAMO THERAPEUTICS INC) before exiting the position in 2026-Q2.

Question 2

What is WELLS FARGO & COMPANY/MN's SGMO position worth?

Accepted Answer

WELLS FARGO & COMPANY/MN's SGMO position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is WELLS FARGO & COMPANY/MN buying or selling SGMO?

Accepted Answer

In 2026-Q2, WELLS FARGO & COMPANY/MN exited their SGMO position entirely (-100.0% change in shares).

Question 4

When did WELLS FARGO & COMPANY/MN first buy SGMO?

Accepted Answer

Based on available 13F filings, WELLS FARGO & COMPANY/MN first reported a position in SGMO in 2023-Q3. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$0.14	0
2026-Q1	Increased	38,330	+1.1%	$9,464	0.0%	$0.39	12
2025-Q4	Decreased	37,918	-5.0%	$15,926	0.0%	$0.43	0
2025-Q3	Decreased	39,907	-7.6%	$26,874	0.0%	$0.70	0
2025-Q2	Decreased	43,172	-18.4%	$23,370	0.0%	$0.54	0
2025-Q1	Increased	52,930	+5.0%	$34,712	0.0%	$0.82	14
2024-Q4	Decreased	50,416	-16.1%	$51,424	0.0%	$2.34	0
2024-Q3	Decreased	60,066	-7.5%	$52,023	0.0%	$0.87	0
2024-Q2	Decreased	64,973	-51.6%	$23,279	0.0%	$0.36	0
2024-Q1	Decreased	134,357	-21.4%	$90,046	0.0%	$0.67	0
2023-Q4	Decreased	170,905	-47.4%	$92,853	0.0%	$0.54	0
2023-Q3	New	324,671	-	$194,737	0.0%	$0.60	32

SGMO12 quarters

SGMO
12 quarters